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Thanks to Drs. Kalra, Balhara, Mezuk,
Pouwer, andCampbell andMs.Macdonald
for their careful consideration (1–3) of
the first American Diabetes Association
(ADA) psychosocial guidelines Position
Statement (4). Kalra and Balhara (1) note
the overlaps and differences in the con-
tent of the ADA and Indian position state-
ments, with particular emphasis on the
cultural appropriateness and specificity
of recommendations. Mezuk and Pouwer
(2) question the need for routine screen-
ing for depression in persons with impaired
glucose metabolism and undiagnosed dia-
betes based on meta-analytic results (5)
and note the need to address disparities
in diabetes burden and quality of care. They
further suggest the need for action steps for
practitioners once psychosocial issues are
identified that impact health outcomes.
These concerns are echoed by Macdonald
and Campbell (3) when identifying that
emphasis on compliance can cause
blame to be placed on patients through
misguided interpretation of the patient-
centered paradigm. They suggest that
this might be avoided through “long-
term” care, by which they appear to
mean the relationship formed through
long-term follow-through by a consis-
tent care provider.
These authors identify social issues
that are not explicitly addressed in the
ADA Position Statement: barriers to getting
married, gender-based issues, geographi-
cally basedmanagement challenges, cultur-
ally specific intervention strategies for
increasing well-being, disparities in burden
and quality of care for racial/ethnic minori-
ties, and the need for relationship-based
care, i.e., provider understanding of per-
sonal needs rather than only reliance on
treatment algorithms. The importance of
individual needs and cultural context is
thereby emphasized. Whether with regard
to phase of life, availability of medical re-
sources, and/orbroader cultural issues that
are endemic and therefore interact with
care, no one set of guidelines or recom-
mendations will be applicable to all people
affected by this global epidemic. Thus, per-
son-based and contextual factors must al-
ways be considered in order to optimize
treatment and outcomes (4).
As noted, some content areas such as
compassion fatigue of caregivers, pro-
vider assumptions regarding burden of
care and burnout, and drug addiction
were not included in the ADA Position
Statement. This first Position Statement
was limited to topics regarding psychoso-
cial issues with evidence-based literature
that included problem prevalence and
effective treatment approaches and that
provided support for recommendations. It
is our expectation that additional evidence-
based reviews and future position state-
ments will address special topics and
populations not covered in this first state-
ment. The need for tested interventions
to remediate disparities in burden of care,
delivery, and quality of care is particularly
critical given exponential increases in
global diabetes prevalence (6).
Also highlighted were issues addressed
in the ADA guidelines but not recom-
mended in European and Indian guidelines:
preconception counseling, diabetes dis-
tress, fear of hypoglycemia, depression
screening for those individuals with pre-
diabetes, etc. The Australian authors (3)
also suggest that patient-centered care
as actually implemented may increase di-
abetes distress and that diabetes self-
management education and support or
psychological treatment may be unable
to alleviate diabetes distress (although
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the review they cited identifies these inter-
ventions as effective strategies). The ADA
Position Statement emphasis on patient-
centered care may reflect the Western
view of health care and individual agency
in determining health outcomes, with em-
phasis on self-management behavior (7)
and decision-making (8), but it needs to
be implemented within a context that
does not engage in patient blaming. An-
other important pointmade byMacdonald
and Campbell (3) is the differences be-
tween approaches to psychological inter-
vention: screening, coping paradigms,
and therapies to facilitate well-being
and adaption to burden of illness. Although
they may be called different thingsdrisk
assessment in the case of depression
(9), interpersonal or cognitive behavioral
therapydsimultaneous medical and psy-
chological treatment has been shown to
potentiate well-being and health for peo-
ple with diabetes (10,11). Given that de-
pression and other psychiatric disorders
are known risk factors for development of
diabetes and a significant percentage of
those affected by diabetes remain undi-
agnosed (9), preclinical screening in vul-
nerable individuals is justified. Effective care
paradigms that include routine screening
and improve well-being and health out-
comes need to be more broadly adapted
and offered. As Mezuk and Pouwer (2)
and Macdonald and Campbell (3) note,
capacity building of providers and health
care systems, as well as actionable pro-
vider treatment algorithms, are key to
achieving this goal. Provider behavior
must also be altered to facilitate shared
treatment goals and decision-making.
How this is best accomplished has not
been systematically studied. Develop-
ment of effective collaborative care sys-
tems and delineation of provider roles in
team care is in its infancy (12). In consid-
ering implementation of the ADA psycho-
social guidelines, it has been suggested
that a systematic review of existing care
systems and provider attitudes and roles
could be informative.
There are now a number of position
statements regarding psychosocial care
that represent foundational steps toaddress
these important issues (13). There are vary-
ing paradigms for provision of care, with
some medical milieus more or less amena-
ble to shareddecision-making, collaborative
care, and long-term care provision. More
effort needs to be made to synthesize and
learn from implementation of recommen-
dations among diverse populations to help
establish best practices that may have
greater universality and/or applicability
to a variety of cultural milieus.
Acknowledgments. The content of this re-
sponse reflects the views of the ADA psychoso-
cial guidelines Position Statement authors. The
National Institutes of Health supports the sci-
ence that informs clinical guidelines.
Funding. Funding for the participation of M.d.G.
in the preparation of this article came in part from
the National Institute of Diabetes and Digestive
and Kidney Diseases (R18-DK-092765). J.G. is
supported by grants from theNational Institute of
Diabetes and Digestive and Kidney Diseases, Na-
tional Institutes of Health (R01-DK-104845, R18-
DK-098742, and P30-DK-111022).
Duality of Interest. F.H.-B. is a member of the
ADA Board of Directors. K.H. has served as a con-
sultant to Bigfoot Biomedical and Johnson &
Johnson Diabetes Institute and received research
support fromDexcom.M.P. has received research
grants from Bristol-Myers Squibb, Genentech,
and Novo Nordisk; has received consulting fees
from AstraZeneca, Calibra, Genentech, Eli Lilly,
and Novo Nordisk; has received speaking hono-
raria from Novo Nordisk; and has participated in
advisory panels for GlaxoSmithKline, Eli Lilly, and
Novo Nordisk. No other potential conflicts of in-
terest relevant to this article were reported.
References
1. Kalra S, Balhara YPS. Comment on Young-
Hyman et al. Psychosocial care for people with
diabetes: a position statement of the American
Diabetes Association. Diabetes Care 2016:39:
2126–2140 (Letter). Diabetes Care 2017;40:e126.
https://doi.org/10.2337/dc16-2599
2. Mezuk B, Pouwer F. Comment on Young-
Hyman et al. Psychosocial care for people with
diabetes: a position statement of the American
Diabetes Association. Diabetes Care 2016:39:
2126–2140 (Letter). Diabetes Care 2017;40:e127–
e128. https://doi.org/10.2337/dc16-2694
3. Macdonald GC, Campbell LV. Comment on
Young-Hyman et al. Psychosocial care for people
with diabetes: a position statement of the Amer-
ican Diabetes Association. Diabetes Care 2016:39:
2126–2140 (Letter). Diabetes Care 2017;40:
e129–e130. https://doi.org/10.2337/dc16-2718
4. Young-Hyman D, de Groot M, Hill-Briggs F,
Gonzalez JS, Hood K, Peyrot M. Psychosocial
care for people with diabetes: a position state-
ment of the American Diabetes Association [pub-
lished corrections appear in Diabetes Care 2017;
40:287 and Diabetes Care 2017;40:726]. Diabetes
Care 2016;39:2126–2140
5. Nouwen A, Nefs G, Caramlau I, et al.; European
Depression in Diabetes Research Consortium.
Prevalence of depression in individuals with im-
paired glucosemetabolismor undiagnoseddiabe-
tes: a systematic review and meta-analysis of the
European Depression in Diabetes (EDID) Research
Consortium. Diabetes Care 2011;34:752–762
6. World Health Organization. Global report on
diabetes [Internet], 2016. Geneva, World Health
Organization. Available fromhttp://apps.who.int/
iris/bitstream/10665/204871/1/9789241565257_
eng.pdf. Accessed 3 May 2017
7. Funnell MM, Brown TL, Childs BP, et al. Na-
tional standards for diabetes self-management ed-
ucation. Diabetes Care 2010;33(Suppl. 1):S89–S96
8. Fitzpatrick SL, Schumann KP, Hill-Briggs F.
Problem solving interventions for diabetes self-
management and control: a systematic review
of the literature. Diabetes Res Clin Pract 2013;
100:145–161
9. Ward M, Druss B. The epidemiology of diabe-
tes in psychotic disorders. Lancet Psychiatry 2015;
5:431–451
10. Gois C, Dias VV, Carmo I, et al. Treatment re-
sponse in type 2 diabetes patients with major de-
pression. Clin Psychol Psychother 2014;21:39–48
11. Safren SA, Gonzalez JS, Wexler DJ, et al. A
randomized controlled trial of cognitive behavior-
al therapy for adherence and depression (CBT-AD)
in patients with uncontrolled type 2 diabetes. Di-
abetes Care 2014;37:625–633
12. Huang Y, Wei X,Wu T, Chen R, Guo A. Collab-
orative care for patients with depression and
diabetes mellitus: a systematic review and
meta-analysis. BMC Psychiatry 2013;13:260
13. Psychosocial Aspects of Diabetes (PSAD) Study
Group. Psychosocial guidelines [Internet]. Avail-
able from https://uvtapp.uvt.nl/tsb11/ws.ws.
frmShowpage?v_page_id53742924699326460.
Accessed 3 May 2017
e132 Response Diabetes Care Volume 40, September 2017
